Don't want ads? Subscribe or login now.

CVS Can't Escape FCA Suit Alleging Drugmaker Collusion

By Daniel Wilson · March 13, 2023, 11:01 PM EDT

A Pennsylvania federal judge has refused to dismiss a whistleblower False Claims Act suit accusing CVS units of colluding with drugmakers to keep Medicare beneficiaries from accessing certain generic drugs, finding...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Opinion

Case Information

Case Title

ELLSWORTH ASSOCIATES, LLP et al v. CVS HEALTH CORPORATION et al

Case Number

2:19-cv-02553

Court

Pennsylvania Eastern

Nature of Suit

Qui Tam (31 U.S.C. § 3729(a))

Date Filed

June 12, 2019

Recent Articles By Daniel

December 19, 2024
Top Gov't Contracts Cases Of 2024
December 09, 2024
Roberts Questions Gov't View On Reservist Top-Up Pay Law
November 26, 2024
CMS Cancels Call Center Solicitation With Disputed Labor Clause
November 18, 2024
AECOM Calls FCA Suit Alleging False Army Billing 'Meritless'
November 04, 2024
Relators Want Denial Of Fluor FCA Legality Argument To Stick
October 23, 2024
Penn State To Pay $1.25M To Resolve FCA Cybersecurity Suit
October 22, 2024
Ga. Tech Says No Basis For Feds' Cybersecurity FCA Suit
October 07, 2024
High Court Rejects Ex-Raytheon Worker's Retaliation Suit
October 01, 2024
Novel FCA Decision Amplifies Voices Of Whistleblower Critics
September 25, 2024
Novel Labor Clause Ruling May Beg Scrutiny In Court